Bangladesh
Vetoquinol India Animal Health P. Ltd
801, Sigma, 8th floor, Hiranandani Business Park
Technology Street - Powai
Mumbai 400 076
MH
India
-
Press
-
Job offers
-
Investors
- Investors
- SHAREHOLDING
- AGENDA
- CORPORATE GOVERNANCE
- SUSTAINABLE DEVELOPMENT
- ETHICS AND ANTI-CORRUPTION
- FINANCIAL INFORMATION
-
SHAREHOLDER'S MEETING
- 7.1 General meeting date and venue
- 7.2 meeting notice published in the French publication for legal announcements (BALO)
- 7.3 Board's report on the compensation policy
- 7.5 Delegations of authority for capital increases at the end of the reporting period
- 7.6 Registration document (URD)
- 7.7 Statutory auditors'report on regulated agreements
- 7.8 Board's report on corporate governance
- 7.9 List of directors and offices
- 7.10 Description of the share buyback program
- 7.11 Statutory Auditors'report on the draft resolutions submitted to the meeting
- 7.12 Document request form
- 7.13 Form for voting by both lail or proxy
- 7.14 Total number of voting rights existing and the number of shares comprising the capital on the publication date of the notice mentioned in article 225-73 of the French commercial Code, specifying, as applicable the number of shares and voting rights
- 7.20 Results of the votes
- PUBLIC RELEASES
-
REGULATED INFORMATION
- 9.1 Annual report
- 9.2 Half year report
- 9.5 Description of the share buyback programs
- 9.10 Information on shareholding threshold
- CONTACT SOCIETES
- LEGAL NOTICE
2022 KEY FIGURES
€540 million
2,500 people
Essential products: €304m
Lastest press releases
-
Press
-
Job offers
-
Investors
- Investors
- SHAREHOLDING
- AGENDA
- CORPORATE GOVERNANCE
- SUSTAINABLE DEVELOPMENT
- ETHICS AND ANTI-CORRUPTION
- FINANCIAL INFORMATION
-
SHAREHOLDER'S MEETING
- 7.1 General meeting date and venue
- 7.2 meeting notice published in the French publication for legal announcements (BALO)
- 7.3 Board's report on the compensation policy
- 7.5 Delegations of authority for capital increases at the end of the reporting period
- 7.6 Registration document (URD)
- 7.7 Statutory auditors'report on regulated agreements
- 7.8 Board's report on corporate governance
- 7.9 List of directors and offices
- 7.10 Description of the share buyback program
- 7.11 Statutory Auditors'report on the draft resolutions submitted to the meeting
- 7.12 Document request form
- 7.13 Form for voting by both lail or proxy
- 7.14 Total number of voting rights existing and the number of shares comprising the capital on the publication date of the notice mentioned in article 225-73 of the French commercial Code, specifying, as applicable the number of shares and voting rights
- 7.20 Results of the votes
- PUBLIC RELEASES
-
REGULATED INFORMATION
- 9.1 Annual report
- 9.2 Half year report
- 9.5 Description of the share buyback programs
- 9.10 Information on shareholding threshold
- CONTACT SOCIETES
- LEGAL NOTICE
2022 KEY FIGURES
€540 million
2,500 people
Essential products: €304m
Lastest press releases
Europe
Asia
Oceania